Results 261 to 270 of about 168,682 (384)

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts [PDF]

, 2003
Mark S. Cragg, Suzanne M. Morgan, H. T. Claude Chan, B. Paul Morgan, Alexander Filatov, Peter Johnson, Ruth R. French, Martin J. Glennie   +7 more
openalex   +1 more source

Mott cells in CD20‐positive myeloma [PDF]

British Journal of Haematology, 2011
Robin M. Ireland, Karthik Ramasamy, Jon Salisbury, Dariusz Ladon   +3 more
openaire   +2 more sources

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas. [PDF]

Cancer Immunol Immunother
Ma J, Sarén T, Jin C, Kim HS, Contreras Pineda PD, de Bernard M, Amini RM, Rondahl V, Enblad G, Yu D, Essand M.   +10 more
europepmc   +1 more source

Bridging the Gap: Guideline Adherence in IgG4‐Related Digestive Disease

United European Gastroenterology Journal, EarlyView.
Katja Kilani, Alexander Kleger
wiley   +1 more source

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab [PDF]

, 2003
J. Boye, T. Elter, A. Engert
openalex   +1 more source

Methyl jasmonate counteracts cadmium toxicity in water spinach plant by adjusting growth, physiology and redox regulation. [PDF]

Sci Rep
Haque MS, Mondal S, Hossain KS, Baroi A, Hussain MT, Mia MA, Uddin MN, Sarwar AKMG, Hossain MA, Islam MA.   +9 more
europepmc   +1 more source

Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours

Andrology, EarlyView.
Abstract Background Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and ...
Sarah C. Moody, Daniela Fietz, Benedict Nathaniel, Mark Frydenberg, Ben Tran, Hans‐Christian Schuppe, Kate L. Loveland   +6 more
wiley   +1 more source

Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20 [PDF]

, 2003
Domenico Sansonno, Vallì De Re, Gianfranco Lauletta, Felicia Anna Tucci, Mauro Boiocchi, Franco Dammacco   +5 more
openalex   +1 more source

COVID-19 Vaccine Boosters in People With Multiple Sclerosis: Improved SARS-CoV-2 Cross-Variant Antibody Response and Prediction of Protection. [PDF]

Neurol Neuroimmunol Neuroinflamm
Yeola A, Houston S, Aggarwal A, Gamage R, Maltby VE, Fabis-Pedrini MJ, Le-Kavanagh L, Merheb V, Nguyen K, Lee FXZ, Walters S, Taha M, O'Connell A, Jokubaitis VG, Roldan A, Monif M, Butzkueven H, Sampangi S, Rath L, Fazzolari K, Hardy TA, Beadnall HN, Barnett MH, Kermode AG, Dwyer C, Kalincik T, Broadley SA, Turville SG, Reddel SW, Ramanathan S, Lechner-Scott J, Van Der Walt A, Brilot F.   +32 more
europepmc   +1 more source

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

British Journal of Haematology, EarlyView.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source